ATM: Functions of ATM Kinase and Its Relevance to Hereditary Tumors

Sayaka Ueno1,2, Tamotsu Sudo1, Akira Hirasawa2

  • 1Section of Translational Research, Hyogo Cancer Center, 13-70 Kita-Oji-cho, Akashi-shi 673-8558, Japan.

Insights

Germline ATM variants increase cancer risk, particularly breast and pancreatic cancers. Targeting ATM-deficient cancers with DNA damage response inhibitors shows promise for new hereditary cancer therapies.

Area of Science:

  • Genetics and Molecular Biology
  • Cancer Biology
  • DNA Damage Response

Background:

  • The Ataxia-telangiectasia mutated (ATM) protein is crucial for cellular responses to DNA damage and stress.
  • ATM signaling regulates DNA repair, apoptosis, cell cycle, and proliferation.
  • Germline pathogenic variants in the ATM gene are linked to increased hereditary cancer risk, especially breast and pancreatic cancers.

Purpose of the Study:

  • To review the structure and function of the ATM gene and kinase.
  • To discuss the clinical significance of ATM germline variants in hereditary cancers.
  • To explore the therapeutic potential of targeting ATM in cancer treatment.

Main Methods:

  • Literature review of ATM gene structure, function, and clinical associations.
  • Analysis of ATM's role in DNA double-strand break repair.
  • Examination of synthetic lethal strategies and ongoing clinical trials involving DNA damage response inhibitors.

Main Results:

  • ATM is a central regulator of DNA damage response pathways.
  • Germline ATM variants confer susceptibility to specific cancers.
  • Targeting DNA repair pathways in ATM-deficient cancers is a promising therapeutic strategy.

Conclusions:

  • Understanding ATM's role is vital for diagnosing and treating hereditary cancers.
  • Inhibitors targeting DNA damage response pathways offer potential for ATM-deficient cancer therapy.
  • Further research into ATM-targeted therapies could improve patient outcomes.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.5K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.9K